Diabetic Macular Edema (DME) Recruiting Phase 3 Trials for Brolucizumab (DB14864)

Also known as: Diabetic Macular Edema(DME) / Diabetic Macular Oedema / Macular Edema, Diabetic / Diabetic Macular Edema / Diabetic retinal oedema / Diabetic retinal edema

IndicationStatusPhase
DBCOND0060562 (Diabetic Macular Edema (DME))Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04058067To Compare Brolucizumab to Aflibercept in Chinese Patients With Visual Impairment Due to Diabetic Macular EdemaTreatment